Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Dev Regulatory News (FDEV)

Share Price Information for Frontier Dev (FDEV)

Share Price is delayed by 15 minutes
Get Live Data
461.50    5.00 (1.10%)
Bid:
455.50
Ask:
460.00
Spread: 4.50 (0.988%)
Market Cap: £160.29m
FDEV Live PriceLast checked at - London Stock Exchange

Intraday Frontier Dev Share Chart

Publishing Partnership Agreement

11 Jun 2019 09:30

RNS Number : 8110B
Frontier Developments PLC
11 June 2019
 

11 June 2019

Frontier Developments plc

Publishing partnership agreement with Haemimont Games

Surviving Mars and Tropico developer first signee to Frontier Publishing

Frontier Developments plc (AIM: FDEV, "Frontier", the "Company"), a leading developer and publisher of videogames based in Cambridge, is pleased to announce a publishing partnership with experienced developer Haemimont Games (the "Agreement").

As referenced in the Company's 2018 annual results, external partnerships (including third party publishing agreements where Frontier brings other developers' games to market) are expected to form an important element within the Company's plans as it continues to grow its portfolio. The Agreement marks the first publishing partnership under Frontier's new Frontier Publishing initiative.

Haemimont Games ("Haemimont"), founded in 1997 in Bulgaria, boasts a passionate team of over 60 highly skilled people and a wealth of experience in the strategy and management game genres, developing the hit title Surviving Mars and titles in the Tropico series. The partnership will see Frontier and Haemimont work together on a new project for release in two to three years' time, with Frontier providing the development funding as well as marketing and distribution.

This deal is strategic and the first step to growing Frontier's publishing business with third party titles. The Board expects the publishing business to become a material contributor to the group in years to come, as more partnerships are agreed.

Frontier CEO David Braben said: "This is a strong start for Frontier Publishing - we're delighted to partner with a studio of the quality of Haemimont. Our Frontier Publishing initiative helps us to further expand our game portfolio through external development partnerships that supplement our own internal development roadmap. We are in discussions with other developers and hope to be able to announce further publishing partnerships in the future."

Gabriel Dobrev, CEO at Haemimont Games said: "Partnering with Frontier, who have a long history with great, innovative titles, is the perfect fit for us at Haemimont Games. We're proud to be the first partner for Frontier Publishing and can't wait to reveal details on our brand new project in the future."

Frontier CCO Jonny Watts said: "Haemimont has a great reputation within the industry and we're excited to start this working relationship. From the beginning of discussions it was clear both companies have a strong passion for the management and strategy genre that makes this an ideal match."

This announcement contains inside information as defined in Article 7 of the Market Abuse Regulation (EU) 596/2014. The person responsible for making this announcement on behalf of the Company is Alex Bevis. 

 

Enquiries:

 

Frontier Developments +44 (0)1223 394 300

David Braben, CEO

Alex Bevis, CFO

Liberum - Nomad and Joint Broker +44 (0)20 3100 2000

Neil Patel / Cameron Duncan

finnCap - Joint Broker +44 (0) 207 220 0500

Matt Goode / Giles Rolls / Alice Lane

Tulchan Communications +44 (0) 207 353 4200

Matt Low

 

 

About Frontier

Frontier is a leading developer and publisher of videogame franchises founded in 1994 by David Braben, co-author of the iconic Elite game. Based in Cambridge, Frontier uses its proprietary 'COBRA' game development technology to create innovative games, currently focusing on videogame consoles and personal computers.

 

Frontier's LEI number: 213800B9LGPWUAZ9GX18.

 

www.frontier.co.uk

 

About Haemimont Games

Haemimont Games is an independent game development team brought together by a common passion: to thrill, engage and provoke gamers worldwide.

Using its own proprietary technology, the studio has developed a number of games including entries in the Tropico series, Victor Vran and Surviving Mars.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGREAPKFFAXNEEF
Date   Source Headline
1st Jun 202612:05 pmRNSEBT Share Purchase
28th May 20262:30 pmRNS-RPlanet Zoo 2 Announced
22nd May 202611:26 amRNS-RWarhammer 40,000: Chaos Gate – Deathwatch Revealed
22nd May 20269:16 amRNSHolding(s) in Company
19th May 20265:47 pmRNSHolding(s) in Company
18th May 202610:48 amRNSEBT Share Purchase
12th May 20267:00 amRNSTrading Update - FY26 Revenue & Profit Upgraded
23rd Apr 20267:00 amRNSCompletion of Share Buyback Programme
23rd Apr 20267:00 amRNSDirector/PDMR Shareholding
23rd Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 202611:05 amRNSHolding(s) in Company
22nd Apr 20267:00 amRNSDirector/PDMR Shareholding
22nd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 20267:00 amRNSDirector/PDMR Shareholding
17th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSDirector/PDMR Shareholding
16th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20267:00 amRNSDirector/PDMR Shareholding
15th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20267:00 amRNSDirector/PDMR Shareholding
14th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 20267:00 amRNSDirector/PDMR Shareholding
10th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20267:00 amRNSDirector/PDMR Shareholding
8th Apr 20267:00 amRNSDirector/PDMR Shareholding
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSDirector/PDMR Shareholding
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSDirector/PDMR Shareholding
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSDirector/PDMR Shareholding
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20267:00 amRNSDirector/PDMR Shareholding
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSDirector/PDMR Shareholding
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:00 amRNSDirector/PDMR Shareholding
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSDirector/PDMR Shareholding
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSDirector/PDMR Shareholding
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSDirector/PDMR Shareholding
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSDirector/PDMR Shareholding
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.